Back to search results

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

T Cell Lymphoma · T-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Yale Cancer Center, Clinical Trials Office, New Haven, Connecticut, United States

    Contact: Study coordinator (Daniel Moncayo) · daniel.moncayo@yale.edu · 203-500-0834
    Contact: Principal Investigator (Tarsheen Sethi, MD)

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Martin van Voorthuysen) · martine.vanvoorthuysen@mssm.edu · 646-745-6092
    Contact: Principal Investigator (Roshan Asrani, MD)
Study leads

  • Tarsheen Sethi, MD

    Principal Investigator

    Yale University

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)